J&J Closes Australian Research Facility As Part Of Global R&D Restructuring Plan
This article was originally published in PharmAsia News
Executive Summary
PERTH, Australia - Johnson & Johnson will close its Australian research facility based in the Australian Technology Park in Redfern as part of a global consolidation and restructuring of its pharma R&D operations, the company announced Aug. 28